Trial intelligence / Profile preview

Apneic Oxygenation via Nasal Cannulae: 15 L/min vs 60 L/min

NCT02755389Phase 4Completed

Sponsor
Nova Scotia Health
Start
Sep 2016
Primary completion
Jun 2018
Modality
Inhalation Devices
Countries
1
01

Overview

Phase 4, randomised trial of oxygen in hypoxemia, sponsored by Nova Scotia Health. Started Sep 2016; status: completed.

02

Drugs

oxygen
03

Conditions

hypoxemia

Beyond the preview

Go deeper on NCT02755389.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02755389.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call